The company has significantly advanced the development of the new treatment for ATTR-CM, utilizing the compound. Early patient data reveals significant benefits for patients diagnosed by the serious condition. The https://attruby623373.bloggerchest.com/42269554/bridgebio-improves-cardiac-amyloidosis-therapy-with-the-drug